Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BIORA THERAPEUTICS, INC. | Director | Common Stock | 31.9K | $61K | $3.14 | Jun 5, 2024 | Direct |
Lineage Cell Therapeutics, Inc. | Chief Financial Officer | Common Shares | 10.5K | $9.35K | $0.89 | Aug 16, 2024 | Direct |
Lineage Cell Therapeutics, Inc. | Chief Financial Officer | Employee Stock Option (Right to Buy) | 650K | Mar 7, 2024 | Direct | ||
BIORA THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 12.5K | Jun 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LCTX | Lineage Cell Therapeutics, Inc. | Aug 16, 2024 | 1 | $9.35K | 4 | Aug 19, 2024 | Chief Financial Officer |
BIOR | BIORA THERAPEUTICS, INC. | Jun 5, 2024 | 2 | $0 | 4 | Jun 6, 2024 | Director |
LCTX | Lineage Cell Therapeutics, Inc. | Mar 7, 2024 | 1 | $0 | 4 | Mar 8, 2024 | Chief Financial Officer |
BIOR | BIORA THERAPEUTICS, INC. | Jun 14, 2023 | 2 | $0 | 4 | Jun 16, 2023 | Director |
LCTX | Lineage Cell Therapeutics, Inc. | Mar 9, 2023 | 1 | $0 | 4 | Mar 10, 2023 | Chief Financial Officer |
BIOR | BIORA THERAPEUTICS, INC. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Director |
LCTX | Lineage Cell Therapeutics, Inc. | Nov 14, 2022 | 1 | $0 | 4 | Nov 16, 2022 | Chief Financial Officer |
LCTX | Lineage Cell Therapeutics, Inc. | Nov 14, 2022 | 0 | $0 | 3 | Nov 16, 2022 | Chief Financial Officer |
BIOR | BIORA THERAPEUTICS, INC. | Jun 15, 2022 | 2 | $0 | 4 | Jun 17, 2022 | Director |
BIOR | PROGENITY, INC. | Nov 3, 2021 | 2 | $0 | 4 | Nov 5, 2021 | Director |
BIOR | PROGENITY, INC. | Nov 3, 2021 | 0 | $0 | 3 | Nov 5, 2021 | Director |